FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to gynecology, and can be used as a preoperative diagnostic level of proliferation in uterine leiomyoma in patients of reproductive age. To realize the method, the relative content of CD336+CD335+ lymphocytes in the CD56+ gate is determined in the first phase of the menstrual cycle in endometrial mononuclear cells localized in the projection of the node. If value is 5.4 % or less, a high level of proliferative activity of uterine leiomyoma cells is diagnosed. If the value is more than 5.4 %, low level of proliferative activity of uterine leiomyoma cells.
EFFECT: preoperative diagnostics of proliferative activity of uterine leiomyoma cells in women of reproductive age, allowing to obtain more informative data better reflecting pathogenetic changes in leiomyoma related to proliferation.
1 cl, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING UTERINE LEIOMYOMA SIZE INCREASE | 2019 |
|
RU2704819C1 |
| METHOD FOR PREDICTING UTERINE LEIOMYOMA SIZE INCREASE | 2019 |
|
RU2704817C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE OF LEIOMYOMA GROWTH PATTERNS | 2013 |
|
RU2542468C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR UTERUS LEIOMYOMA GROWTH TYPE | 2008 |
|
RU2361216C1 |
| DIAGNOSTIC TECHNIQUE FOR DISTURBED ENDOMETRIAL RECEPTIVITY IN PATIENTS SUFFERING UTERINE MYOMA AND INFERTILITY | 2014 |
|
RU2553340C1 |
| METHOD FOR RAPID HYSTEROMYOMA DEVELOPMENT PREDICTION | 2016 |
|
RU2626676C1 |
| METHOD FOR PREDICTING THE PROBABILITY OF DEVELOPMENT OF PROLIFERATING UTERUS MYOMA | 2018 |
|
RU2676035C1 |
| METHOD FOR PREDICTING GROWTH RATE OF UTERINE LEIOMYOMA IN WOMEN OF REPRODUCTIVE AGE | 2018 |
|
RU2690379C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR SIMPLE AND FAST-GROWING HYSTEROMYOMA WITH NORMAL ENDOMETRIAL PATTERN | 2014 |
|
RU2572229C1 |
| METHOD FOR TREATING HYPERPLASTIC ENDOMETRIAL PROCESSES COMBINED WITH UTERINE MYOMA | 2006 |
|
RU2317103C1 |
